Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients

NCT04898270 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia; Psychosis
Metabolic Syndrome
Flupentixol
Antipsychotic Agents
Central Nervous System Diseases
Clinical Therapy
Olanzapine
Quetiapine

Interventions

DRUG: Flupentixol
DRUG: Multi-acting receptor-targeted antipsychotics (MARTAs)

Sponsor

Taichung Veterans General Hospital